Development of progesterone receptor antagonists from 1,2-dihydrochromeno[3,4-f]quinoline agonist pharmacophore
摘要:
A series of 1,2-dihydrochromeno[3,4-f]quinoline derivatives was synthesized and tested in biological assays to evaluate the nonsteroidal progesterone receptor modulator pharmacophore (4) as antiprogestins. A number of potent analogues were identified by modification of the substituents at the D-ring. (C) 2003 Elsevier Science Ltd. All rights reserved.
The Synthesis of Substituted Benzo[c]chromen-6-ones by a Suzuki Coupling and Lactonization Sequence Using Ionic Liquids – from Laboratory Scale to Multi-Kilogram Synthesis
作者:Gerardus J. Kemperman、B. Ter Horst、D. Van de Goor、T. Roeters、J. Bergwerff、R. Van der Eem、J. Basten
DOI:10.1002/ejoc.200600188
日期:2006.7
A series of benzo[c]chromen-6-ones are prepared by a Suzukicoupling and lactonization sequence starting with 2-methoxyphenylboronic acids and methyl 2-bromobenzoate derivatives. The use of ionic liquids in this synthesis has been explored. It was found that the Suzukicoupling proceeds much faster when a catalytic amount of the ionic liquid [BMIM][PF6] is used. By using the Lewis acidic ionic liquids
NOVEL 1,2-DIHYDROQUINOLINE DERIVATIVE HAVING (SUBSTITUTED PHENYL OR SUBSTITUTED HETEROCYCLIC) CARBONYLOXY LOWER ALKYL GROUP AND ESTER-INTRODUCED PHENYL GROUP AS SUBSTITUENTS
申请人:Matsuda Mamoru
公开号:US20090298826A1
公开(公告)日:2009-12-03
The compounds represented in general formula (1) and a salt thereof are useful for glucocorticoid receptor modulator.
The R
1
represents a hydrogen atom or a lower alkyl group; R
2
represents a hydrogen atom or a lower alkyl group; R
3
and R
4
may be the same or different and represent a hydrogen atom or a lower alkyl group; R
5
represents a hydrogen atom or a lower alkyl group; R
6
represents a halogen atom, a lower alkyl group, a hydroxy group, a lower alkoxy group, a nitro group or a cyano group; X represents —C(O)—, —C(O)NR
8
—, —S(O)
2
— and the like; R
7
and/or R
8
may be the same or different and represent a hydrogen atom, a lower alkyl group which may have a substituent, an aryl group which may have a substituent, a heterocyclic group which may have a substituent, a lower alkoxy group which may have a substituent and the like; Y represents a lower alkylene group; Z represents a benzene ring or a heterocyclic ring; and P represents 0, 1, 2 or 3.
Synthesis of Dibenzopyranones through Palladium-Catalyzed Directed C-H Activation/Carbonylation of 2-Arylphenols
作者:Shuang Luo、Fei-Xian Luo、Xi-Sha Zhang、Zhang-Jie Shi
DOI:10.1002/anie.201304295
日期:2013.9.27
Dibenzopyranones were synthesized by a palladium‐catalyzed phenol‐directed C–H activation/carbonylation of 2‐phenylphenol derivatives in the presence of CO. Pd(OAc)2 was used as a catalyst and Cu(OAc)2 as a catalytic oxidant in the presence of air.
NOVEL 1,2-DIHYDROQUINOLINE DERIVATIVE HAVING SUBSTITUTED PHENYLAMINO LOWER ALKYL GROUP AND ESTER-INTRODUCED PHENYL GROUP AS SUBSTITUENTS
申请人:Matsuda Mamoru
公开号:US20090298827A1
公开(公告)日:2009-12-03
The compounds represented in general formula (1) and a salt thereof are useful for glucocorticoid receptor modulator.
The R
1
represents a hydrogen atom or a lower alkyl group; R
2
represents a hydrogen atom or a lower alkyl group; R
3
and R
4
may be the same or different and represents a hydrogen atom or a lower alkyl group; R
5
represents a hydrogen atom or a lower alkyl group; R
6
represents a halogen atom, a lower alkyl group, a hydroxy group, a lower alkoxy group, a nitro group or a cyano group; X represents —C(O)—, —C(O)NR
8
—, —S(O)
2
— and the like; R
7
and/or R
8
may be the same or different and represent a hydrogen atom, a lower alkyl group which may have a substituent, an aryl group which may have a substituent, a heterocyclic group which may have a substituent, a lower alkoxy group which may have a substituent and the like; Y represents a lower alkylene group; and P represents 0, 1, 2 or 3.
Method for preventing or treating a disease related to the glucocorticoid receptor
申请人:Matsuda Mamoru
公开号:US20110275620A1
公开(公告)日:2011-11-10
A method for preventing or treating a disease related to the glucocorticoid receptor involving administering a pharmacologically effective amount of a 1,2-hydroquinoline compound.